Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(36%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_2
5
45%
Ph not_applicable
2
18%
Ph phase_4
4
36%

Phase Distribution

0

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
5(45.5%)
Phase 4Post-market surveillance
4(36.4%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting3
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (45.5%)
Phase 44 (36.4%)
N/A2 (18.2%)

Trials by Status

unknown218%
completed545%
active_not_recruiting19%
recruiting327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11